FDA Clearance Tracker · P180034
Tack Endovascular System (6F)
Last checked: Nov 20, 2026Latest source record: Apr 11, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Apr 11, 2019
Approval withdrawn
Time to decision
223 days
Received Aug 31, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P180034
- Device name
- Tack Endovascular System (6F)
- Applicant location
- Plymouth, MN
- Received
- Aug 31, 2018
- Decided
- Apr 11, 2019
- Decision
- Approval withdrawn
- Supplements
- 7 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Scaffold, dissection repair (QCT)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for use in the superficial femoral and proximal popliteal arteries ranging in diameter from 3.5mm to 6.0mm for the repair of post percutaneous transluminal balloon angioplasty dissection(s).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QCT (Scaffold, dissection repair).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Philips Image Guided Therapy Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- IntraSight Plus510(k)
K253714 · Decided Feb 24, 2026 · 92 days after receipt
Device type: System, Imaging, Pulsed Echo, Ultrasonic (IYO) · Radiology & Imaging
K251103 · Decided May 9, 2025 · 28 days after receipt
Device type: Catheter, Ultrasound, Intravascular (OBJ) · Cardiology
P230021 · Decided Dec 26, 2023 · 176 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.